enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Ubrogepant - Wikipedia

    en.wikipedia.org/wiki/Ubrogepant

    Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. [ 4 ] [ 5 ] It is not indicated for the preventive treatment of migraine. [ 6 ]

  3. Medicare Part D - Wikipedia

    en.wikipedia.org/wiki/Medicare_Part_D

    Plans can change the drugs on their formulary during the course of the year with 60 days' notice to affected parties. The primary differences between the formularies of different Part D plans relate to the coverage of brand-name drugs. Typically, each Plan's formulary is organized into tiers, and each tier is associated with a set co-pay amount.

  4. Medicare Prescription Drug, Improvement, and Modernization Act

    en.wikipedia.org/wiki/Medicare_Prescription_Drug...

    Medicare Modernization Act — includes PDF file of the actual text of the law. Medicare.gov — the official website for people with Medicare Medicare Modernization Act at Medicare.gov; Prescription Drug Coverage homepage at Medicare.gov — a central location for Medicare's web-based information about the Part D benefit

  5. Does Medicare cover Ozempic? Yes — but it depends on your Rx

    www.aol.com/finance/does-medicare-cover-ozempic...

    The Medicare donut hole — also called the Medicare coverage gap — is a term used to refer to the temporary limit on what your plan will pay for prescription drugs. After your plan’s payments ...

  6. List of drugs granted breakthrough therapy designation

    en.wikipedia.org/wiki/List_of_drugs_granted...

    In combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth-factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant ...

  7. J&J's chemotherapy-free treatment for lung cancer gets US ...

    www.aol.com/news/us-fda-approves-j-js-111733970.html

    The approval allows the use of the cancer drug, Rybrevant, in combination with J&J's existing drug, lazertinib, as a first-line treatment for non-small cell lung cancer (NSCLC) patients with a ...

  8. 340B Drug Pricing Program - Wikipedia

    en.wikipedia.org/wiki/340B_Drug_Pricing_Program

    The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible ...

  9. North American Association of Central Cancer Registries

    en.wikipedia.org/wiki/North_American_Association...

    The North American Association of Central Cancer Registries, Inc. is a professional organization that develops and promotes uniform data standards for cancer registration; provides education and training; certifies population-based registries; aggregates and publishes data from central cancer registries; and promotes the use of cancer surveillance data and systems for cancer control and ...